Images List Premium Download Classic

Vasocon

Vasocon-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Core body temperature management of an anesthetized patient
Board Of Regents, The University Of Texas System
May 10, 2018 - N°20180125703

The present application relates to systems and methods for altering the core body temperature in a mammalian body. For example, a method may include maintaining the patient in a general anesthetic state by administration of at least an anesthetic agent to the patient, wherein the anesthetic agent prevents vasoconstriction of avas in the patient's glabrous tissue. The method may also ...
Treatment systems processes and devices addressing cerebral vasospasm/vasoconstriction
Neurvana Medical, Llc
March 01, 2018 - N°20180055666

Endovascular treatment of, for example, delayed cerebral vasospasm involves the placing of a microcatheter in the affected vessels followed by the teachings of the instant disclosure, which is clinically improved with comparison to slow infusion of a vasodilating compound. Systems, processes and self-expanding designed stents and stent-like members are featured and highlighted. The stents and stent-like members being retrieved, nothing ...
Compositions and methods for regulating blood pressure
University Of Virginia Patent Foundation
February 01, 2018 - N°20180028595

Both purinergic signaling through nucleotides such as atp and noradrenergic signaling through molecules such as norepinephrine regulate vascular tone and blood pressure. Pannexin1 (panx1), which forms large-pore, atp-releasing channels, is present in vascular smooth muscle cells in peripheral blood vessels and participates in noradrenergic responses. Using pharmacological approaches and mice conditionally lacking panx1 in smooth muscle cells, we found that ...
Vasocon Patent Pack
Download + patent application PDFs
Vasocon Patent Applications
Download + Vasocon-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vasocon-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Iglass: infrared thermography for learning thermoregulation performance
University Of Southern California
September 21, 2017 - N°20170265755

An infrared thermography based technique is described for monitoring an individual's thermoregulation performance and thermal comfort level through measuring the skin temperature on several points the face as the face has a high density of blood vessels and it is typically not covered by clothing. This technique allows for continuous monitoring during normal daily activities and instantaneous identification of thermoregulation ...
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Omeros Corporation
August 31, 2017 - N°20170246150

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that demonstrates substantial agonist activity at alpha adrenergic receptors and that is selected for peripheral (local) vasoconstriction and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline ...
Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues
Cryosa, Llc
August 31, 2017 - N°20170246032

A heat exchanger is disclosed for causing cryolysis of adipose tissue of a human tongue. The heat exchanger includes a body having cooling channels for circulating fluids therein. The body forms a contact surface that contacts a portion of the dorsal surface of the tongue and a portion of the base of the tongue. The heat exchanger includes a pair ...
Vasocon Patent Pack
Download + patent application PDFs
Vasocon Patent Applications
Download + Vasocon-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vasocon-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Tumescent drug delivery
August 03, 2017 - N°20170216198

A method of subcutaneous delivery of a drug or a therapeutic agent to a subject comprising administering to said subject a mass of fluid of a tumescent composition comprising: (a) the drug or the therapeutic agent; (b) a vasoconstrictor; and (c) a pharmaceutically acceptable carrier, wherein a relatively large total amount of the drug is isolated from systemic circulation in ...
Novel hemostatic patch and uses thereof
July 06, 2017 - N°20170189573

Disclosed herein is a novel hemostatic patch that may be used to control and/or arrest bleeding in patients. The patch offers an effective but also minimally invasive way to control and/or arrest bleeding in a patient. The patch comprises a mucoadhesive and a compound that causes vasoconstriction. In a preferred aspect, the patch comprises chitosan and neuropeptide y. ...
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Omeros Corporation
June 29, 2017 - N°20170182007

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that exhibits alpha- adrenergic activity and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated ringer's solution. The solution is applied by continuous irrigation of ...
Treatment systems processes and devices addressing cerebral vasospasm/vasoconstriction
March 30, 2017 - N°20170086992

Endovascular treatment of, for example, delayed cerebral vasospasm involves the placing of a microcatheter in the affected vessels followed by the teachings of the instant disclosure, which is clinically improved with comparison to slow infusion of a vasodilating compound. Systems, processes and self-expanding designed stents and stent-like members are featured and highlighted. The stents and stent-like members being retrieved, nothing ...
Control of blood vessel physiology to treat skin disorders
Biochemics, Inc.
August 18, 2016 - N°20160235846

In a method for treating an affected skin region of a patient having a skin disorder, a vasodilation composition is applied to an affected skin region of a patient, the affected skin region exhibiting a skin disorder characterized by at least one abnormal blood vessel, and the affected skin region is then treated so as to non-invasively disrupt tissue architecture, ...
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
June 30, 2016 - N°20160184272

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that demonstrates substantial agonist activity at alpha adrenergic receptors and that is selected for peripheral (local) vasoconstriction and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline ...
Novel hemostatic patch and uses thereof
June 02, 2016 - N°20160151532

Disclosed herein is a novel hemostatic patch that may be used to control and/or arrest bleeding in patients. The patch offers an effective but also minimally invasive way to control and/or arrest bleeding in a patient. The patch comprises a mucoadhesive and a compound that causes vasoconstriction. In a preferred aspect, the patch comprises chitosan and neuropeptide y. ...
Vasocon Patent Pack
Download + patent application PDFs
Vasocon Patent Applications
Download + Vasocon-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vasocon-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for treating pulmonary hypertension
The Medicines Company
May 19, 2016 - N°20160136196

The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting adp-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible p2y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing ...
Composition and method for treating nosebleeds
Binyarco, Llc
May 12, 2016 - N°20160128970

A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline. The composition is preferably a paste administered intranasally.
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Omeros Corporation
May 05, 2016 - N°20160120846

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that exhibits alpha-adrenergic activity and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated ringer's solution. The solution is applied by continuous irrigation of a ...
Therapeutic suit
April 28, 2016 - N°20160113812

The therapeutic suit reliefs joint pain by applying heat or cold relief to one or all joints of the body and bringing healing to joints by vasoconstriction, centralizing oxygenated blood around the joints during cold therapy treatment.
Method and system for providing an early risk recognition monitoring
Medieta Oy
March 24, 2016 - N°20160081628

A system for providing an early risk recognition monitoring by measurement of a peripheral tissue perfusion of a patient instead of clinically significant changes in systemic blood pressure and/or blood flow comprises a wristband device for gathering measurement data of the patient. The device measures a first temperature (t1) of the patient at the first wrist (or distal antebrachium) ...
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Omeros Corporation
March 10, 2016 - N°20160067219

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that exhibits alpha-adrenergic activity and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated ringer's solution. The solution is applied by continuous irrigation of a ...
Salvinorin compositions and uses thereof
The Trustees Of The University Of Pennsylvania
December 24, 2015 - N°20150366840

The invention relates to salvinorin compositions and uses thereof. Specifically, the invention relates to administering salvinorin compositions to treat diseases and disorders associated with vasoconstriction, vaso-occlusion, or disruption of blood flow and autoregulation. For example, salvinorin compositions may be administered to subjects with cardiac arrest, subarachnoid hemorrhage, stroke, cerebral vascular spasm, cerebral hypoxia/ischemia, cerebral artery occlusion, or any condition ...
Composition for prevention of vasoactivity in the treatment of blood loss and anemia
October 15, 2015 - N°20150290213

The present invention relates to the prevention of cardiovascular and central nervous system side effects in mammals who receive transfusions of hemoglobin based oxygen carriers (hboc) or stored blood products containing a concentration of hemoglobin sufficient to induce vasoconstriction, by adding a vasoactivity reducing effective amount of one or more phosphodiesterase inhibitors in combination with a calcium channel blocker and/...
Loading